Randomized clinical trial of single-incision versus multiport laparoscopic colectomy

Area of Science:

• Colorectal Surgery
• Minimally Invasive Surgery
• Surgical Oncology

Background:

• The clinical effectiveness and safety of single-incision laparoscopic colectomy (SILC) for colon cancer are not well-established.
• Existing research has not definitively compared SILC with multiport laparoscopic colectomy (MPLC).

Purpose of the Study:

• To compare the surgical outcomes of SILC versus MPLC in patients with colon cancer.
• To evaluate the safety and efficacy of SILC in a randomized controlled trial.

Main Methods:

• A randomized controlled trial involving 200 patients with Stage 0-III colon cancer.
• Patients were assigned to either SILC or MPLC, with complete mesocolic excision performed.
• Safety and surgical outcomes were analyzed based on randomization groups.

Main Results:

• No significant differences were observed in operation duration, blood loss, conversion rates, reoperation rates, time to first flatus, or postoperative hospital stay between SILC and MPLC.
• SILC resulted in a significantly shorter skin incision length compared to MPLC (4.4 cm vs. 6.8 cm).
• Overall complication rates were comparable between the two surgical approaches.

Conclusions:

• Single-incision laparoscopic colectomy (SILC) is not superior to multiport laparoscopic colectomy (MPLC) for colon cancer.
• Both techniques offer similar oncological and short-term surgical outcomes, with SILC providing a cosmetic advantage.